Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Arrhythmias

Epinephrine test for sudden cardiac death—is it too early?

Nature Reviews Cardiology volume 9, pages 675–676 (2012)Cite this article

Subjects

Unexplained sudden cardiac death (SCD) is a major health problem, and prediction and identification of high-risk populations remain a challenge. Epinephrine stress testing could help to identify individuals at risk of SCD, but more research is required before this test could be recommended for routine use.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Schematic representation of the Mayo Clinic protocol for epinephrine stress test.

References

  1. Ackerman, M. J. et al. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin. Proc. 77, 413–421 (2002).

    Article  CAS  Google Scholar 

  2. Shimizu, W. & Antzelevitch, C. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J. Am. Coll. Cardiol. 35, 778–786 (2000).

    Article  CAS  Google Scholar 

  3. Krahn, A. D. et al. Epinephrine infusion in the evaluation of unexplained cardiac arrest and familial sudden death: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry. Circ. Arrhythm. Electrophysiol. 5, 933–940 (2012).

    Article  CAS  Google Scholar 

  4. Ackerman, M. J. Cardiac channelopathies: it's in the genes. Nat. Med. 10, 463–464 (2004).

    Article  CAS  Google Scholar 

  5. Kapplinger, J. D. et al. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm 6, 1297–1303 (2009).

    Article  Google Scholar 

  6. Vyas, H., Hejlik, J. & Ackerman, M. J. Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response. Circulation 113, 1385–1392 (2006).

    Article  CAS  Google Scholar 

  7. Noda, T. et al. Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur. Heart J. 23, 975–983 (2002).

    Article  CAS  Google Scholar 

  8. Montanez, A., Ruskin, J. N., Hebert, P. R., Lamas, G. A. & Hennekens, C. H. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch. Intern. Med. 164, 943–948 (2004).

    Article  Google Scholar 

  9. Zhang, Y. et al. Electrocardiographic QT interval and mortality: a meta-analysis. Epidemiology 22, 660–670 (2011).

    Article  Google Scholar 

  10. Soliman, E. Z. et al. Prolongation of QTc and risk of stroke: The REGARDS (REasons for Geographic and Racial Differences in Stroke) study. J. Am. Coll. Cardiol. 59, 1460–1467 (2012).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology, Guggenheim 501, 200 First Street SW, Rochester, 55905, MN, USA

    J. Martijn Bos & Michael J. Ackerman

Authors
  1. J. Martijn Bos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. Ackerman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J. Ackerman.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bos, J., Ackerman, M. Epinephrine test for sudden cardiac death—is it too early?. Nat Rev Cardiol 9, 675–676 (2012). https://doi.org/10.1038/nrcardio.2012.155

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2012.155

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing